Stellular Bio, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Stellular Bio, Inc. - overview
Established
2014
Location
Watertown, MA, US
Primary Industry
Biotechnology
About
Established in 2014 and based in Massachusetts, US, Stellular Bio, Inc. , formerly known as Platelet BioGenesis, Inc. , operates as a biotechnology company that provides platelet‑derived regenerative biologic therapies for ocular surface disease.
Current Investors
Vivo Capital, Qiming Venture Partners, eCoast Angel
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.stellularbio.com
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.